Robert Barrow - 12 Mar 2025 Form 4 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Role
Chief Executive Officer, Director
Signature
/s/ Mark Sullivan, Attorney-in-Fact for Robert Barrow
Issuer symbol
MNMD
Transactions as of
12 Mar 2025
Net transactions value
$0
Form type
4
Filing time
13 Mar 2025, 16:30:13 UTC
Previous filing
27 Dec 2024
Next filing
26 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNMD Common Shares Award $0 +350,000 +66% $0.000000 877,764 12 Mar 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
F2 Amount includes 1,098 shares acquired under the Mind Medicine (MindMed) Inc. 2024 Employee Share Purchase Plan on February 18, 2025.